Buchang Pharmaceuticals (603858.SH): Qianlie Shutong Capsules receive marketing authorization approval in Indonesia

Zhitong Finance APP news, Buchang Pharmaceuticals (603858.SH) announced that recently, the company received marketing authorization approval from the National Agency of Drug and Food Control of the Republic of Indonesia. The product Qianlie Shutong Capsules of the company's wholly-owned subsidiary Baoding Tianhao Pharmaceutical Co., Ltd. has been approved for traditional medicine registration.